𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Discovery of Novel Stem Cell Mobilizers That Target the CXCR4 Receptor

✍ Scribed by Dr. Chien-Huang Wu; Dr. Chun-Ping Chang; Dr. Jen-Shin Song; Jiing-Jyh Jan; Ming-Chen Chou; Szu-Huei Wu; Kai-Chia Yeh; Dr. Ying-Chieh Wong; Chieh-Jui Hsieh; Dr. Chiung-Tong Chen; Tzu-Ting Kao; Dr. Su-Ying Wu; Ching-Fang Yeh; Dr. Chen-Tso Tseng; Dr. Yu-Sheng Chao; Dr. Kak-Shan Shia

Book ID
112066653
Publisher
John Wiley and Sons
Year
2011
Tongue
English
Weight
349 KB
Volume
7
Category
Article
ISSN
1860-7179

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Hematopoietic stem cell mobilization wit
Hematopoietic stem cell mobilization with the reversible CXCR4 receptor inhibitor plerixafor (AMD3100)β€”Polish compassionate use experience
✍ Grzegorz Wladyslaw Basak; Wanda Knopinska-Posluszny; Magdalena Matuszak; Elzbiet πŸ“‚ Article πŸ“… 2010 πŸ› Springer 🌐 English βš– 225 KB

Recent developments in the field of targeted therapy have led to the discovery of a new drug, plerixafor, that is a specific inhibitor of the CXCR4 receptor. Plerixafor acts in concert with granulocyte colony-stimulating factor (G-CSF) to increase the number of stem cells circulating in the peripher